
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-11-02-2016
- Volume 11
- Issue 11
NJIT Researchers Honored for API Coating Technology
The researchers were awarded the Thomas Alva Edison Patent Award for a solventless method for coating APIs.
A team of engineers from the New Jersey Institute of Technology (NJIT) are the recipients of a Thomas Alva Edison Patent Award from the Research & Development Council of New Jersey for developing a manufacturing process that masks the bitter taste of medications. The group of researchers include Rajesh Davé, distinguished professor of chemical, biological, and pharmaceutical engineering, and two of his former graduate students Maxx Capece, senior scientist at AbbVie, and Daniel To, senior product development scientist at Colorcon. The group will receive the award during a ceremony on Nov. 3, 2016.
The NJIT researcher’s patent (
The awards are given to patent work spanning 11 categories including agriculture, biotechnology, defense, drug delivery technology, enabling technology, energy, industrial process, industrial product, medical device, medical technology, and telecommunications. Other award recipients include Honeywell, ExxonMobil, Immunomedics, Lockheed Martin, Merck, NJIT, Nokia Bell Labs, Princeton Plasma Physics Laboratory, Rutgers University Siemens, and TE Connectivity.
Source:
Articles in this issue
about 9 years ago
Pharma Assesses Technologies to Prevent Fakesabout 9 years ago
Outlook for Fill/Finish Outsourcing Stays Healthyabout 9 years ago
A Global Fight to Protect the Drug Supplyabout 9 years ago
Interpharm Praha A.S Receives FDA Warning Letterabout 9 years ago
Multi-Tenant Warehouse Option Aids Healthcare Companiesabout 9 years ago
Catalent Breaks Ground for Expanded Biologics Facilityabout 9 years ago
ICH Introduces Two New Guidelinesabout 9 years ago
Recipharm to Open New GLP Bioanalysis Laboratory in Swedenabout 9 years ago
CordenPharma Completes API Process BayNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





